QQQ   308.92 (-0.63%)
AAPL   158.36 (-1.18%)
MSFT   276.88 (-1.32%)
META   202.93 (-1.50%)
GOOGL   102.63 (-2.67%)
AMZN   98.24 (+0.11%)
TSLA   192.37 (+1.03%)
NVDA   265.12 (-1.00%)
NIO   8.98 (-0.99%)
BABA   86.11 (-0.91%)
AMD   96.78 (-1.19%)
T   18.89 (+1.50%)
F   11.55 (+0.35%)
MU   60.04 (-1.83%)
CGC   1.89 (-0.65%)
GE   93.21 (+2.01%)
DIS   95.83 (+1.86%)
AMC   4.53 (+1.34%)
PFE   40.19 (-0.50%)
PYPL   73.45 (-0.58%)
NFLX   328.34 (-0.02%)
QQQ   308.92 (-0.63%)
AAPL   158.36 (-1.18%)
MSFT   276.88 (-1.32%)
META   202.93 (-1.50%)
GOOGL   102.63 (-2.67%)
AMZN   98.24 (+0.11%)
TSLA   192.37 (+1.03%)
NVDA   265.12 (-1.00%)
NIO   8.98 (-0.99%)
BABA   86.11 (-0.91%)
AMD   96.78 (-1.19%)
T   18.89 (+1.50%)
F   11.55 (+0.35%)
MU   60.04 (-1.83%)
CGC   1.89 (-0.65%)
GE   93.21 (+2.01%)
DIS   95.83 (+1.86%)
AMC   4.53 (+1.34%)
PFE   40.19 (-0.50%)
PYPL   73.45 (-0.58%)
NFLX   328.34 (-0.02%)
QQQ   308.92 (-0.63%)
AAPL   158.36 (-1.18%)
MSFT   276.88 (-1.32%)
META   202.93 (-1.50%)
GOOGL   102.63 (-2.67%)
AMZN   98.24 (+0.11%)
TSLA   192.37 (+1.03%)
NVDA   265.12 (-1.00%)
NIO   8.98 (-0.99%)
BABA   86.11 (-0.91%)
AMD   96.78 (-1.19%)
T   18.89 (+1.50%)
F   11.55 (+0.35%)
MU   60.04 (-1.83%)
CGC   1.89 (-0.65%)
GE   93.21 (+2.01%)
DIS   95.83 (+1.86%)
AMC   4.53 (+1.34%)
PFE   40.19 (-0.50%)
PYPL   73.45 (-0.58%)
NFLX   328.34 (-0.02%)
QQQ   308.92 (-0.63%)
AAPL   158.36 (-1.18%)
MSFT   276.88 (-1.32%)
META   202.93 (-1.50%)
GOOGL   102.63 (-2.67%)
AMZN   98.24 (+0.11%)
TSLA   192.37 (+1.03%)
NVDA   265.12 (-1.00%)
NIO   8.98 (-0.99%)
BABA   86.11 (-0.91%)
AMD   96.78 (-1.19%)
T   18.89 (+1.50%)
F   11.55 (+0.35%)
MU   60.04 (-1.83%)
CGC   1.89 (-0.65%)
GE   93.21 (+2.01%)
DIS   95.83 (+1.86%)
AMC   4.53 (+1.34%)
PFE   40.19 (-0.50%)
PYPL   73.45 (-0.58%)
NFLX   328.34 (-0.02%)
TSE:CPH

Cipher Pharmaceuticals - CPH Competitors

C$3.32
-0.03 (-0.90%)
(As of 03/27/2023 03:16 PM ET)
Add
Compare
Today's Range
C$3.28
C$3.41
50-Day Range
C$3.34
C$3.87
52-Week Range
C$2.00
C$4.07
Volume
13,909 shs
Average Volume
13,319 shs
Market Capitalization
C$83.27 million
P/E Ratio
7.22
Dividend Yield
N/A
Price Target
N/A

CPH vs. RX, NINE, TGOD, HEXO, WMD, CWEB, CRDL, VIR, ZOM, and IN

Should you be buying Cipher Pharmaceuticals stock or one of its competitors? The main competitors of Cipher Pharmaceuticals include BioSyent (RX), Delta 9 Cannabis (NINE), Green Organic Dutchman (TGOD), HEXO (HEXO), WeedMD (WMD), Charlotte's Web (CWEB), Cardiol Therapeutics (CRDL), Viridium Pacific Group (VIR), Zomedica Pharmaceuticals Corp. (ZOM.V) (ZOM), and InMed Pharmaceuticals (IN). These companies are all part of the "drug manufacturers - specialty & generic" industry.

Cipher Pharmaceuticals vs.

Cipher Pharmaceuticals (TSE:CPH) and BioSyent (CVE:RX) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, media sentiment, community ranking, risk, earnings, profitability, analyst recommendations and valuation.

Cipher Pharmaceuticals has a net margin of 128.83% compared to BioSyent's net margin of 0.00%. Cipher Pharmaceuticals' return on equity of 51.73% beat BioSyent's return on equity.

Company Net Margins Return on Equity Return on Assets
Cipher Pharmaceuticals 128.83% 51.73% 11.01%
BioSyent N/A 19.38% 13.03%

In the previous week, BioSyent had 10 more articles in the media than Cipher Pharmaceuticals. MarketBeat recorded 10 mentions for BioSyent and 0 mentions for Cipher Pharmaceuticals. BioSyent's average media sentiment score of 0.58 beat Cipher Pharmaceuticals' score of 0.00 indicating that BioSyent is being referred to more favorably in the news media.

Company Overall Sentiment
Cipher Pharmaceuticals Neutral
BioSyent Positive

Cipher Pharmaceuticals has a beta of 1.02, suggesting that its share price is 2% more volatile than the S&P 500. Comparatively, BioSyent has a beta of 0.78, suggesting that its share price is 22% less volatile than the S&P 500.

Cipher Pharmaceuticals received 82 more outperform votes than BioSyent when rated by MarketBeat users. However, 66.20% of users gave BioSyent an outperform vote while only 62.41% of users gave Cipher Pharmaceuticals an outperform vote.

CompanyUnderperformOutperform
Cipher PharmaceuticalsOutperform Votes
176
62.41%
Underperform Votes
106
37.59%
BioSyentOutperform Votes
94
66.20%
Underperform Votes
48
33.80%

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cipher Pharmaceuticals
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00
BioSyent
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

0.2% of Cipher Pharmaceuticals shares are owned by institutional investors. Comparatively, 1.3% of BioSyent shares are owned by institutional investors. 42.7% of Cipher Pharmaceuticals shares are owned by company insiders. Comparatively, 40.6% of BioSyent shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Cipher Pharmaceuticals has higher earnings, but lower revenue than BioSyent. Cipher Pharmaceuticals is trading at a lower price-to-earnings ratio than BioSyent, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cipher PharmaceuticalsC$20.68 million4.03C$26.64 millionC$0.467.22
BioSyentC$27.68 million3.28C$6.14 millionC$0.4915.31

Summary

Cipher Pharmaceuticals and BioSyent tied by winning 8 of the 16 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CPH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CPH vs. The Competition

MetricCipher PharmaceuticalsDrug Manufacturers IndustryMedical SectorTSE Exchange
Market CapC$83.27MC$1.47BC$4.31BC$3.66B
Dividend YieldN/A1.57%5.98%6.98%
P/E Ratio7.2260.9497.5723.66
Price / Sales4.0310,843.823,427.751,094.72
Price / Cash3.539.8627.0674.04
Price / Book1.303.154.494.03
Net IncomeC$26.64M-C$47.31MC$114.18MC$341.25M
7 Day Performance-4.32%-1.37%1.48%0.98%
1 Month Performance-12.63%-5.29%-5.29%-1.95%
1 Year Performance38.91%-31.25%-15.53%4.99%

Cipher Pharmaceuticals Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
RX
BioSyent
0 of 5 stars
C$7.25
-1.1%
N/A-16.8%C$87.73MC$27.68M14.80N/AAnalyst Revision
News Coverage
NINE
Delta 9 Cannabis
0 of 5 stars
C$1.03
+3.0%
N/A+0.0%C$89.36MC$12.87M19.0779News Coverage
Gap Up
TGOD
Green Organic Dutchman
0 of 5 stars
N/AN/AN/AC$89.95MC$31.37M-0.6541Gap Up
High Trading Volume
HEXO
HEXO
1.3971 of 5 stars
C$1.66
-7.3%
C$6.25
+276.7%
-86.4%C$73.04MC$148.08M-0.062,021
WMD
WeedMD
0 of 5 stars
C$0.28
-1.8%
N/A+0.0%C$67.82MC$27.53M-0.66212Negative News
Gap Up
CWEB
Charlotte's Web
0 of 5 stars
C$0.43
+2.4%
C$0.70
+64.7%
N/AC$64.44MC$80.10M-0.29N/AGap Up
CRDL
Cardiol Therapeutics
0 of 5 stars
C$0.66
-1.5%
C$4.00
+506.1%
-60.9%C$42.04MN/A-1.53N/AGap Up
VIR
Viridium Pacific Group
0 of 5 stars
C$0.38
+5.6%
N/A+0.0%C$37.52MC$1.09M-2.97N/AGap Up
ZOM
Zomedica Pharmaceuticals Corp. (ZOM.V)
0 of 5 stars
C$0.29
-6.6%
N/A+0.0%C$36.73MN/A-2.6127Positive News
Gap Down
IN
InMed Pharmaceuticals
0 of 5 stars
N/AN/AN/AC$33.73MC$574,677.00-2.7712News Coverage
This page (TSE:CPH) was last updated on 3/27/2023 by MarketBeat.com Staff